News
For years, the financial technology industry has touted its ability to spot good credit risks missed by big banks and traditional lenders, providing people...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow I aim to invest in companies with perfect qualitative attributes, buy them at an attractive price based on...
News
This article was written by Follow Author and entrepreneur. My articles typically cover macroeconomic trends, portfolio strategy, value investing, and behavioral finance. I like...
News
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
News
Back in March, I put a “Sell” rating on Beyond Meat (NASDAQ:BYND), noting that the company had made a number of missteps over the...
News
You know the formula. Major news event happens, and financial news outlets, including MarketWatch, use the story as a peg to discuss a broader...
News
Basing all student loan outcomes on the borrower’s income seems to be all the rage these days, and that’s true whether we’re talking about...
News
Author’s note: This article was released to CEF/ETF Income Laboratory members on June 4th. A reader asked for my thoughts on the iShares Core...
News
Co-authored with PendragonY In recent years, Electric Vehicles (‘EVs’) have become more popular and common. While Tesla (TSLA) is the most well-known of the...
News
This is reprinted by permission from The investing information provided on this page is for educational purposes only. NerdWallet, Inc. does not offer advisory...
News
Business updates The past quarter proved challenging for 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) with a drop in total revenue by 11.1% to $417.6 million. Despite this,...
News
Americans bought fewer used cars in May than they did one year before. But the number of certified pre-owned (CPO) car sales rose. Overall...
News
My Verve Therapeutics (NASDAQ:VERV) thesis rests on the idea that while the clinical hold that the FDA put on VERV-101’s IND crushed the stock,...
